SCHEMBL1185696

SCHEMBL1185696

CCOC(=O)C1CC(=O)Nc2ccc(Cl)cc2C1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
KDM4E B2RXH2 2/20 0.53
ALDH1A1 P00352 2/20 0.53
GAA P10253 2/20 0.53
HPGD P15428 1/20 0.53
HSD17B10 Q99714 1/20 0.53
LMNA P02545 2/20 0.46
MAPK1 P28482 2/20 0.43
TSHR P16473 3/20 0.40
TP53 P04637 1/20 0.39
RECQL P46063 1/20 0.39
IDO1 P14902 2/20 0.39
TDO2 P48775 2/20 0.39
ABCC1 P33527 1/20 0.39
TGM2 P21980 1/20 0.39
GPBAR1 Q8TDU6 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
ADORA2B P29275 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1185078 0.86 MEN1 (0.53) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL1184356 0.86 GAA (0.53) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL1184927 0.83 ALDH1A1 (0.55) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL27236981 0.79 KMT2A (0.72) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL1184871 0.79 ALDH1A1 (0.53) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL1184778 0.77 CES1 (0.40)
SCHEMBL7824596 0.76 LMNA (0.53) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL23460007 0.74 MEN1 (0.57) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL31145892 0.74 ALDH1A1 (0.47) MAPTMEN1KMT2AKDM4EALDH1A1
SCHEMBL7817550 0.73 LMNA (0.53) MAPTMEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799684-B1 LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS MILLENNIUM PHARM INC (US) 2014-12-03 EP disclosed
US-20120178739-A1 LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-07-12 US disclosed
US-7935694-B2 Lactam compounds useful as protein kinase inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-05-03 US disclosed
US-20110039820-A1 LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-02-17 US disclosed
US-20090105213-A1 Lactam compounds useful as protein kinase inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2009-04-23 US disclosed
US-7459448-B2 Lactam compounds useful as protein kinase inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2008-12-02 US disclosed
US-20060100194-A1 Lactam compounds useful as protein kinase inhibitors MILLENNIUM PHARMACEUTICALS, INC. 2006-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100194-A1 Lactam compounds useful as protein kinase inhibitors PRKCI, PIK3CA, AKT1 MAPT 2225/4885MEN1 1532/4885KMT2A 2007/4885
US-20120178739-A1 LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS PRKCI, PIK3CA, AKT1 MAPT 2225/4885MEN1 1532/4885KMT2A 2007/4885
US-20090105213-A1 Lactam compounds useful as protein kinase inhibitors PRKCI, PIK3CA, AKT1 MAPT 2225/4885MEN1 1532/4885KMT2A 2007/4885
US-20110039820-A1 LACTAM COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS PRKCI, PIK3CA, AKT1 MAPT 2225/4885MEN1 1532/4885KMT2A 2007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.